Lifespan Health and Aging
Featured Topics
Lead story
Other featured articles
-
Prospects for Future Advances in Alzheimer’s Disease
This paper revisits expert predictions for future advances in Alzheimer’s disease (AD) made in 2001 and projects future breakthroughs over the next 20 years.
Posted in -
Sex, Race, and Age Differences in Prevalence of Dementia in Medicare Claims and Survey Data
This study provides the first comparison of trends in dementia prevalence in the U.S. population using 3 different dementia ascertainments/data sources. They found there are still substantial differences across measures in dementia prevalence among Blacks and Hispanics.
Posted in -
Measures and Models for Longevity and Aging: The Burden of Mortality from COVID-19
Ho suggests that researchers need to recognize the strengths and limitations of data produced from life expectancy models in the short-term, and also appreciate the crucial role such models will play in understanding the evolution of population health in the long term.
Posted in -
The Economic Case for Public Investment in Stem Cell Research
Our analysis shows the measure resulted in over 56,000 jobs created and added approximately $10 billion to the state’s economy.
Posted in
About this section
People are living longer, which brings obvious benefits as well as considerable challenges — from Alzheimer’s and other age-related diseases to increased injuries, disabilities and poverty risks. Policymakers around the world rely on Schaeffer Center research and modeling tools for finding ways to help keep people as healthy as possible throughout their lives.
Our Experts On Lifespan Health and Aging
Our Work In Lifespan Health and Aging
-
Older Adults Living Alone Report Higher Rates of Anxiety and Depression
One-quarter of older adults live alone – more than in any other country. Social and physical restrictions may pose particular challenges for these individuals.
Categorized in -
American Capitalism Is Failing Trump’s Base as White Working-Class ‘Deaths of Despair’ Rise
The astronomical costs of health care are draining jobs, hope and opportunity from working-class Americans.
Categorized in -
America Can Afford a World-Class Health System. Why Don’t We Have One?
“Our system takes from the poor and working class to generate wealth for the already wealthy,” Deaton and Case write in The New York Times.
Categorized in -
Association of Combination Statin and Antihypertensive Therapy With Reduced Alzheimer’s Disease and Related Dementia Risk
Drugs already being used to treat high blood pressure and cholesterol could reduce the risk of Alzheimer’s disease and dementia, according to a new Schaeffer Center study of nearly 700,000 Medicare beneficiaries.
Categorized in -
Conflicts of Interest in Dialysis: A Barrier to Policy Reforms
What are the possible benefits and risks of nephrologist’s financial participation in dialysis facility joint venture (JV) arrangements and financial participation in End‐stage Kidney Disease Seamless Care Organizations (ESCOs)? Eugene Lin and co-authors examine possible mechanisms for disclosure and reporting of such arrangements as well as risk mitigation.
Categorized in -
Four Years Into MACRA: What Has Changed?
Changes to nephrology reimbursement present a unique opportunity to improve patient outcomes in a cost‐effective way. A multidisciplinary effort among policy makers, nephrology providers, and patient advocacy groups is critical to ensure these changes in care delivery safeguard and improve patient health.
Categorized in